Fundraising Fox

Esperovax

Plymouth, US · 2 known investors

Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Founders & leadership

RN
Roger Newton
SN
Savita Nikam
DO
David O'HaganCo-founder, President, and CEO

Investors · 2

Michigan Rise✓ verifiedEast Lansing · $50K – $150K
ID VenturesDetroit · $50K – $250K

Frequently asked questions

What does Esperovax do?
Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.
Who are Esperovax's investors?
Esperovax's investors include Michigan Rise, ID Ventures.
Where is Esperovax headquartered?
Esperovax is headquartered in Plymouth, US.